Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sale...
Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requ...
Cohesity, a U.S.-based data security software company, is set to acquire the data protection business of Veritas, a subsidiary ...
U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday. Following the market openin...
Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options ...
https://www.wsj.com/articles/softbank-backed-medical-genetics-company-invitae-prepares-for-bankruptcy-d468f120?st=02yzwzf1bnabm...
Invitae (NYSE:NVTA), a leading medical genetics company, today announced a partnership with BridgeBio Pharma, Inc. (NASDAQ:BBI...
